Macarimbor, Payadoc S.
HRN: 24-96-94 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2024
CLINDAMYCIN 300MG (CAP)
05/04/2024
05/11/2024
ORAL
300mg
Q 6hrs
Tonsillitis
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes